[ad_1]
New Delhi, India. Multidrug-resistant tuberculosis, as lethal as ebola and difficult to treat even in the best hospitals, is a growing global threat, warned Peter Sands, director of the Global Fund to Fight AIDS, Tuberculosis and Malaria , in an interview with AFP.
Multidrug-resistant tuberculosis, with a mortality rate of 50% comparable to Ebola, is only diagnosed in a quarter of cases and is extremely difficult to treat. "If we think about the threats to the global health risk, we should turn on the red light," Sands warned in New Delhi. A preparatory meeting for the next triennial conference on the financing of the Global Fund is held on Friday [19659002] This body, created in 2002 as a result of collaboration between public authorities, civil society, the sector and patients, is particularly interested in cases of antimicrobial resistant TB, estimated at 558 000 worldwide.
This disease "does not know border or need a visa. (…) For now, about 25% of these 558,000 cases are diagnosed and in treatment," said Sands, who has led the Global Fund since last year.
The number of deaths from AIDS and malaria has decreased. about half since the beginning of the century. Tuberculosis, currently the most deadly infectious disease in the world, with 1.3 million deaths a year (with the exception of HIV co-infections), caused about 20% of deaths in 2016 compared to 2000.
Progress remains too modest in view of the goal of eradicating these three epidemics by 2030 – a deadline set by the UN
The risk of control exercised by the health authorities, the stagnation of international investments in health and the development of aid
In this context, the Global Fund aims to reach 14 billion USD (14 billion USD) . for the 2020-2022 period, 1.8 billion more than the amount achieved for 2017-2019.
In several African countries, the Global Fund uses Coca-Cola's powerful distribution network to distribute drugs in isolated clinics. "In the most remote places in most countries, you can find a Coca-Cola, not use their trucks, their supply network, help us transport drugs to places where people need them," explains Sands
[ad_2]
Source link
